Manages symptom complex of tension (or muscle contraction) headache. ANDA 74951, held by Stevens J. Aspirin; Butalbital; Caffeine; Codeine Phosphate.
As of Nov 15, 2026, ANDA 74951 (Butalbital, Aspirin, Caffeine, And Codeine Phosphate), held by Stevens J, was first approved by FDA on Aug 31, 1998, with 9 approved supplements and 0 published complete response letters.
BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE is indicated for the management of the symptom complex of tension (or muscle contraction) headache, when non-opioid analgesic and alternative treatments are inadequate.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 31, 1998 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Butalbital, Aspirin, Caffeine, And Codeine Phosphate325MG;50MG;40MG;30MG · capsule;oral | Aspirin; Butalbital; Caffeine; Codeine Phosphate | Rx |
| Jun 18, 2026 | Supplement 13REMS | Approved | None posted |
| Dec 22, 2025 | Supplement 11Labeling · Standard review | Approved | None posted |
| Nov 21, 2024 | Supplement 10Labeling · Standard review | Approved | None posted |
| Oct 31, 2024 | Supplement 9REMS | Approved | None posted |
| Oct 9, 2024 | Supplement 8Labeling · Standard review | Approved | None posted |
| Dec 15, 2023 | Supplement 7Labeling · Standard review | Approved | None posted |
| Dec 11, 2023 | Supplement 5Labeling · Standard review | Approved | None posted |
| Sep 18, 2018 | Supplement 4REMS | Approved | None posted |
| Nov 9, 2007 | Supplement 2Labeling | Approved | None posted |
| Aug 31, 1998 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters